0
0

Department of Veterans Affairs Awarded a Contract to OPTUM PHARMACY 801, INC. for $350,000.00

Signed on

10/1/2024, 12:00 AM

OPTUM PHARMACY 801, INC. Government Contract #36C26225N0059

OPTUM PHARMACY 801, INC. was awarded a contract with the United States Government for $350,000.00. The contract was awarded by the agency office 262-NETWORK CONTRACT OFFICE 22 (36C262), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is Optum Pharmacy 801, Inc., a U.S.-owned business based in Phoenix, Arizona. The contract is for compounded chemotherapy base drugs and is funded by the Department of Veterans Affairs for $350,000. A notable transaction shows a payment of -$270,441.80 to Optum Pharmacy 801, Inc. on July 17, 2025.

Contract Details

Contract ID36C26225N0059
Contract TypeC
Total Obligation$350,000.00
Exercised Options$350,000.00
Base Amount + Options$350,000.00
Date Signed2024-10-01
Contract DescriptionCOMPOUNDED CHEMOTHERAPY BASE DO
Start Date2024-10-01
End Date2025-09-30

Agency Details

Awarding AgencyDepartment of Veterans Affairs
Awarding Sub AgencyDepartment of Veterans Affairs
Awarding Office262-NETWORK CONTRACT OFFICE 22 (36C262)
Funding AgencyDepartment of Veterans Affairs
Funding Sub AgencyDepartment of Veterans Affairs
Funding Office600-VA LONG BEACH HLTCAR SYS(00600)

Recipient Details

RecipientOPTUM PHARMACY 801, INC.
Recipient Location23620 N 20TH DRIVE PHOENIX ARIZONA, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #P00001$-270,441.80July 17, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $-270,441.80 to OPTUM PHARMACY 801, INC.. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #0$350,000.00October 1, 2024

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $350,000.00 to OPTUM PHARMACY 801, INC.. The payment included a Subsidy Cost of $0.00.

Transaction #P00002$-75,000.00December 30, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $-75,000.00 to OPTUM PHARMACY 801, INC.. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #P00001$-270,441.80July 17, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $-270,441.80 to OPTUM PHARMACY 801, INC.. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #0$350,000.00October 1, 2024

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $350,000.00 to OPTUM PHARMACY 801, INC.. The payment included a Subsidy Cost of $0.00.

Latest Bills

Campus Lifeline Act of 2026
Bill HR 8657May 21, 2026
ADAPT Assets Act
Bill HR 8653May 21, 2026
Transportation Security Administration Transfer Act of 2026
Bill HR 8701May 21, 2026
Uyghur Forced Labor Disclosure Act
Bill HR 8712May 21, 2026
Honoring mothers, and recognizing the significance of motherhood and the impact mothers have on raising the next generation, on the occasion of Mother's Day.
Bill HRES 1273May 21, 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-07: Reasonable Investigation of Consumer Reporting Disputes".
Bill HJRES 181May 21, 2026
Expressing support for the designation of May 2026 as "Arthritis Awareness Month".
Bill HRES 1271May 21, 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Statement of Policy Regarding Prohibition on Abusive Acts or Practices".
Bill HJRES 180May 21, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Statement of Policy Regarding Prohibition on Abusive Acts or Practices".
Bill SJRES 147May 21, 2026
Shared Micromobility Investment Act
Bill HR 8719May 21, 2026